東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Advances in cancer treatment = from ...

Cavalcanti, Iago Dillion Lima.

FindBook

Google Book

Amazon

博客來

Advances in cancer treatment = from systemic chemotherapy to targeted therapy /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Advances in cancer treatment/ by Iago Dillion Lima Cavalcanti, Jose Cleberson Santos Soares.
其他題名:	from systemic chemotherapy to targeted therapy /
作者:	Cavalcanti, Iago Dillion Lima.
其他作者:	Soares, Jose Cleberson Santos.
出版者:	Cham :Springer International Publishing : : 2021.,
面頁冊數:	viii, 109 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Cancer - Treatment. -
電子資源:	https://doi.org/10.1007/978-3-030-68334-4
ISBN:	9783030683344

Advances in cancer treatment = from systemic chemotherapy to targeted therapy /
Cavalcanti, Iago Dillion Lima.

Advances in cancer treatmentfrom systemic chemotherapy to targeted therapy /[electronic resource] :by Iago Dillion Lima Cavalcanti, Jose Cleberson Santos Soares. - Cham :Springer International Publishing :2021. - viii, 109 p. :ill., digital ;24 cm.

This work covers the pathophysiology of cancer, exploring the difficulty of optimal treatment due to the complexity and diversity of cancer types. The search for distinctive molecular biology characteristics of tumor cells is especially relevant in the identification of overexpressed receptors and proteins that can be used as a target for cancer treatment. We highlight the main therapeutic modalities, particularly conventional systemic chemotherapy, addressing its mechanisms of action, therapeutic classes and even the toxic effects. We also describe the main tumor markers, their importance in the diagnosis and treatment of cancer, and the specificity of tumor cells. The first chapters serve as an introduction to the central topic of this book, targeted therapy. Key aspects of target therapy, such as classes of drugs, immunotherapy, monoclonal antibodies, checkpoint inhibitors, cancer vaccines and tyrosine kinase inhibitors are presented, and, for each one, the benefits, as well as the adverse effects are reported. Chapter 6 compares conventional systemic chemotherapy and targeted therapy, identifies the risks and benefits and also the eligibility criteria for patient care. The possibility of targeted therapy replacing conventional chemotherapy is discussed while reviewing studies that demonstrate the benefits of combining both types of treatment. Finally, the introduction of pharmaceutical nanotechnology to improve antineoplastic agents is addressed in the last chapter and sets the direction for future research in cancer treatment. This is a valuable resource for many health professionals including physicians, pharmacists, nurses, researchers and students interested in the field of oncology.

ISBN: 9783030683344

Standard No.: 10.1007/978-3-030-68334-4doiSubjects--Topical Terms:

618125
Cancer
--Treatment.

LC Class. No.: RC270.8 / .C35 2021

Dewey Class. No.: 616.99406

Advances in cancer treatment = from systemic chemotherapy to targeted therapy /
LDR:02742nmm a2200313 a 4500 001 2238522
003 DE-He213
005 20210224093451.0
006 m d
007 cr nn 008maaau
008 211111s2021 sz s 0 eng d
020 $a 9783030683344 $q (electronic bk.)
020 $a 9783030683337 $q (paper)
024 7 $a 10.1007/978-3-030-68334-4 $2 doi
035 $a 978-3-030-68334-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC270.8 $b .C35 2021
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99406 $2 23
090 $a RC270.8 $b .C376 2021
100 1 $a Cavalcanti, Iago Dillion Lima. $3 3491732
245 1 0 $a Advances in cancer treatment $h [electronic resource] : $b from systemic chemotherapy to targeted therapy / $c by Iago Dillion Lima Cavalcanti, Jose Cleberson Santos Soares.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a viii, 109 p. : $b ill., digital ; $c 24 cm.
520 $a This work covers the pathophysiology of cancer, exploring the difficulty of optimal treatment due to the complexity and diversity of cancer types. The search for distinctive molecular biology characteristics of tumor cells is especially relevant in the identification of overexpressed receptors and proteins that can be used as a target for cancer treatment. We highlight the main therapeutic modalities, particularly conventional systemic chemotherapy, addressing its mechanisms of action, therapeutic classes and even the toxic effects. We also describe the main tumor markers, their importance in the diagnosis and treatment of cancer, and the specificity of tumor cells. The first chapters serve as an introduction to the central topic of this book, targeted therapy. Key aspects of target therapy, such as classes of drugs, immunotherapy, monoclonal antibodies, checkpoint inhibitors, cancer vaccines and tyrosine kinase inhibitors are presented, and, for each one, the benefits, as well as the adverse effects are reported. Chapter 6 compares conventional systemic chemotherapy and targeted therapy, identifies the risks and benefits and also the eligibility criteria for patient care. The possibility of targeted therapy replacing conventional chemotherapy is discussed while reviewing studies that demonstrate the benefits of combining both types of treatment. Finally, the introduction of pharmaceutical nanotechnology to improve antineoplastic agents is addressed in the last chapter and sets the direction for future research in cancer treatment. This is a valuable resource for many health professionals including physicians, pharmacists, nurses, researchers and students interested in the field of oncology.
650 0 $a Cancer $x Treatment. $3 618125
650 1 4 $a Oncology. $3 751006
650 2 4 $a Internal Medicine. $3 858559
650 2 4 $a Pharmacy. $3 636101
650 2 4 $a Cancer Research. $3 891172
700 1 $a Soares, Jose Cleberson Santos. $3 3491733
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-68334-4
950 $a Medicine (SpringerNature-11650)